Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-5.63%
operating margin TTM
14.95%
revenue TTM
215.18 Million
revenue per share TTM
1.03$
valuation ratios | |
|---|---|
| pe ratio | -21.81 |
| peg ratio | -0.29 |
| price to book ratio | -1.64 |
| price to sales ratio | 1.08 |
| enterprise value multiple | 0.87 |
| price fair value | -1.64 |
profitability ratios | |
|---|---|
| gross profit margin | 64.44% |
| operating profit margin | 14.95% |
| pretax profit margin | -5.17% |
| net profit margin | -5.63% |
| return on assets | -4.87% |
| return on equity | 5.62% |
| return on capital employed | 36.51% |
liquidity ratios | |
|---|---|
| current ratio | 0.56 |
| quick ratio | 0.21 |
| cash ratio | 0.56 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 267.66 |
| operating cycle | 394.59 |
| days of payables outstanding | 165.67 |
| cash conversion cycle | 228.92 |
| receivables turnover | 2.88 |
| payables turnover | 2.20 |
| inventory turnover | 1.36 |
debt and solvency ratios | |
|---|---|
| debt ratio | 1.18 |
| debt equity ratio | -1.81 |
| long term debt to capitalization | 2.94 |
| total debt to capitalization | 2.23 |
| interest coverage | 0.71 |
| cash flow to debt ratio | -0.02 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.05 |
| cash per share | 0.71 |
| operating cash flow per share | -0.06 |
| free cash flow operating cash flow ratio | 0.99 |
| cash flow coverage ratios | -0.02 |
| short term coverage ratios | -0.15 |
| capital expenditure coverage ratio | -69.28 |
Frequently Asked Questions
When was the last time Esperion Therapeutics, Inc. (NASDAQ:ESPR) reported earnings?
Esperion Therapeutics, Inc. (ESPR) published its most recent earnings results on 06-11-2025.
What is Esperion Therapeutics, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Esperion Therapeutics, Inc. (NASDAQ:ESPR)'s trailing twelve months ROE is 5.62%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Esperion Therapeutics, Inc. (ESPR) currently has a ROA of -4.87%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did ESPR's net profit margin stand at?
ESPR reported a profit margin of -5.63% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is ESPR's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 0.56 in the most recent quarter. The quick ratio stood at 0.21, with a Debt/Eq ratio of -1.81.